![Michel Gardet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Gardet
Director/Miembro de la Junta en
Phagenesis Ltd.
.
Perfil
Michel Gardet is currently a Director at Phagenesis Ltd. He was formerly a Director at Glycom A and Global Head-Business Operations at Nestle Health Science SA.
Cargos activos de Michel Gardet
| Empresas | Cargo | Inicio |
|---|---|---|
Phagenesis Ltd.
 Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michel Gardet.
| Empresas | Cargo | Fin |
|---|---|---|
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Director de Operaciones | - |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
10
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
- Bolsa de valores
- Insiders
- Michel Gardet
